Always verify pricing and state availability on the provider's website before signing up.How our reviews work →

Found vs Ro

An in-depth comparison of two leading GLP-1 Providers

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

7.6

Found

Best for mainstream telehealth GLP-1 access
★★★3.8

Starting at $129/mo

CompoundedSemaglutideTirzepatide
Visit Found
7.9

Ro

Best for broadest GLP-1 formulary including Foundayo on day-one of launch
★★★★4

Starting at $149/mo

CompoundedBrandSemaglutideTirzepatide
Visit Ro

Side-by-Side Comparison

FeatureFoundRo
Overall Score7.6/107.9/10
Starting Price$129/mo$149/mo
Editorial Rating3.8 ★ /54 ★ /5
Features3 features7 features
States Available500
Compounded✓ Yes
Brand Name✓ Yes
FSA/HSA Accepted
FDA WarningsNoneNone

Pros & Cons

Found

Pros

  • Aggressively low monthly pricing
  • Both semaglutide and tirzepatide available
  • Compounded GLP-1 access

Cons

  • Limited public information on program details

Ro

Pros

  • One of the broadest GLP-1 menus: compounded semaglutide, brand Wegovy, brand Zepbound, and oral Foundayo (orforglipron)
  • Among the first telehealth platforms to offer oral Foundayo at launch (April 2026)
  • A licensed provider helps you pick the best GLP-1 based on cost, insurance, and your health goals
  • Nationwide delivery, including 99% of primary-care deserts
  • Both cash-pay and insurance-eligible options on one platform

Cons

  • Foundayo requires a recurring membership on top of the $149/mo drug price, so total cost runs higher
  • Foundayo pricing above the lowest dose isn't shown until intake
  • State availability and pharmacy partners aren't listed publicly — confirmed at signup
  • Membership and medication are billed separately, which can make the true monthly cost confusing

Our Verdict

Winner: RoScore: 7.9/10

Ro edges out Found with a higher overall score of 7.9/10 and is particularly strong for broadest GLP-1 formulary including Foundayo on day-one of launch. Found remains a solid alternative, especially if you're looking for mainstream telehealth GLP-1 access.

Glossary references

Key terms in this article, linked to their canonical definitions.

Related comparisons

Continue exploring Found and Ro head-to-heads in the same category.

Or see the full category ranking.

Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.